Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-22

FDA Approved: CORLANOR — Original Application (Amgen Inc)

View source ↗

Summary

The FDA approved CORLANOR (ivabradine) under Amgen's original NDA, marking the initial approval of the product for its indicated use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corlanor (ivabradine)

Snippet

ORIG AP for CORLANOR (IVABRADINE)